Veterinary Microbiology High-Yield Topics for the NAVLE

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Diagnostic Prioritization: For bacterial infections, cytology and Gram stain are often more cost-effective and rapid than culture for initial antimicrobial guidance, especially when awaiting results or facing resource constraints.
• Bacterial Identification Principles: Gram stain morphology (e.g., cocci vs. rods, Gram-positive vs. Gram-negative) combined with biochemical tests like catalase, coagulase, hemolysis patterns, and oxidase reactions are crucial for narrowing differential diagnoses of bacterial pathogens.
• Zoonotic Pathogen Significance: High-yield zoonotic pathogens such as Brucella, Salmonella, Campylobacter, and Leptospira necessitate understanding occupational exposure risks and public health reporting requirements.
• Viral Pathogenesis and Diagnostics: Viral classification based on nucleic acid type (DNA vs. RNA) and envelope status influences environmental stability and disinfection efficacy; PCR is a primary diagnostic modality due to its sensitivity and speed.
• Fungal Diagnosis: Systemic mycoses are diagnosed via cytology, histopathology, culture, and antigen testing, with urine antigen tests for Blastomyces and Histoplasma offering rapid results, while dermatophytes require specific culture media and Wood's lamp examination for Microsporum canis.
• Antimicrobial Selection: Empiric therapy is justified for unstable patients or pending culture results, targeting likely pathogens based on species and signalment, but must be reassessed within 48-72 hours based on clinical response, with duration guided by infection site and resolution, not fixed timelines.

The North American Veterinary Licensing Examination (NAVLE) assesses the clinical knowledge and decision-making skills expected of a newly graduated veterinarian. Microbiology questions appear throughout the examination, embedded in clinical scenarios that test your ability to identify pathogens, select diagnostic tests, and understand the pathogenesis of infectious disease. This article focuses on the bacteria, viruses, and fungi most frequently represented on the examination, with emphasis on clinical presentation, diagnostic reasoning, and zoonotic implications.

This reference serves veterinary students preparing for the NAVLE and practicing clinicians seeking a structured review. The content is organized by pathogen groups and clinical syndromes, prioritizing organizms with distinctive features that examination questions commonly target. The ICVA NAVLE Candidate Information describes the examination structure and content areas, which include microbiology as a foundational discipline integrated into organ-system questions instead of tested in isolation.

The examination rewards recognition of classic associations: a specific host species, a characteriztic lesion, a unique diagnostic finding, or a public health concern. This review emphasizes those associations while providing the pathophysiologic context that allows you to reason through unfamiliar presentations.

At a Glance

Bacterial Classification and Diagnostic Reasoning

Bacterial identification begins with Gram stain morphology and biochemical characteriztics. The NAVLE expects you to predict likely pathogens based on Gram reaction, shape, arrangement, and oxygen requirements. Gram-positive organizms retain crystal violet due to thick peptidoglycan, while Gram-negative organizms have an outer membrane containing lipopolysaccharide that triggers endotoxic shock. These structural differences determine susceptibility to antimicrobial classes, disinfectant efficacy, and host inflammatory responses.

Catalase testing distinguishes staphylococci and micrococci from streptococci and enterococci. Coagulase testing further separates Staphylococcus aureus from coagulase-negative species. Hemolysis patterns on blood agar provide additional discrimination: beta-hemolysis indicates complete red cell lysis, alpha-hemolysis produces green discoloration, and gamma-hemolysis shows no change. Streptococcus pyogenes, S. equi, and S. zooepidemicus are beta-hemolytic, while enterococci are typically gamma-hemolytic.

Gram-negative identification relies on oxidase reaction, lactose fermentation on MacConkey agar, and triple sugar iron reactions. Pasteurella and Bordetella are oxidase-positive, while Enterobacteriaceae are oxidase-negative. Lactose fermenters include Escherichia coli and Klebsiella, whereas Salmonella and Proteus are non-lactose fermenters. These biochemical distinctions narrow the differential diagnosis before confirmatory testing.

Anaerobic and Spore-Forming Bacteria

Clostridium species produce potent exotoxins responsible for distinct clinical syndromes. Clostridium tetani elaborates tetanospasmin, which blocks inhibitory neurotransmitter release and causes spastic paralysis. Clostridium botulinum produces botulinum toxin, which cleaves SNARE proteins and causes flaccid paralysis. Clostridium perfringens causes enterotoxemia in multiple species, gas gangrene, and hemorrhagic gastroenteritis. Clostridium difficile causes antibiotic-associated colitis, particularly in horses and hospitalized patients.

Diagnosis of clostridial disease often relies on toxin detection instead of culture, because clostridia are normal intestinal inhabitants. Anaerobic culture requires specialized transport media and incubation conditions. Gram stain of affected tissues may reveal large gram-positive rods with subterminal spores. The MSD Veterinary Manual provides species-specific descriptions of clostridial syndromes and their management.

Bacillus anthracis is a non-motile, spore-forming rod that causes peracute septicemia in ruminants. The organizm produces a tripartite toxin with edema and lethal factors. Diagnosis relies on blood smear showing encapsulated gram-positive rods, culture on selective media, and PCR. Anthrax is a reportable disease with significant zoonotic potential, and carcass necropsy should be avoided because sporulation occurs on oxygen exposure.

Intracellular and Fastidious Bacteria

Brucella species are facultative intracellular pathogens that cause reproductive failure and zoonotic brucellosis. Brucella abortus affects cattle, B. melitensis affects small ruminants, and B. suis affects swine. Organizms localize in the placenta, fetal fluids, and mammary tissue, causing abortion storms and retained placenta. Diagnosis uses serology with rose bengal agglutination as a screening test and complement fixation or ELISA for confirmation. Culture requires biosafety level 3 facilities due to aerosol transmission risk.

Mycoplasma species lack a cell wall and therefore do not stain with Gram stain. They require cholesterol-enriched media and grow slowly, producing characteriztic fried-egg colonies. Mycoplasma bovis causes pneumonia, arthritis, and mastitis in cattle. Mycoplasma hyopneumoniae is a primary agent of enzootic pneumonia in swine. Mycoplasma gallisepticum causes chronic respiratory disease in poultry. Diagnosis increasingly relies on PCR because culture is slow and fastidious.

Chlamydia and Chlamydophila species are obligate intracellular bacteria causing conjunctivitis, pneumonia, and abortion. Chlamydia psittaci causes psittacosis in birds and zoonotic respiratory disease in humans. Chlamydia abortus causes enzootic abortion in ewes. Diagnosis uses PCR, antigen detection, and serology. Rickettsial organizms such as Anaplasma, Ehrlichia, and Neorickettsia are transmitted by arthropod vectors and infect hematopoietic cells.

Viral Pathogenesis and Diagnostic Principles

Viral classification on the NAVLE centers on nucleic acid type, genome structure, and envelope status. DNA viruses include parvoviruses, herpesviruses, adenoviruses, and poxviruses. RNA viruses include paramyxoviruses, orthomyxoviruses, coronaviruses, flaviviruses, and retroviruses. Enveloped viruses acquire their lipid membrane from host cell membranes during budding and are susceptible to lipid solvents and detergents. Non-enveloped viruses resist environmental degradation and persist on fomites.

Diagnostic testing for viral disease uses virus isolation, antigen detection, nucleic acid amplification, and serology. PCR has become the primary diagnostic modality because of its sensitivity, speed, and ability to detect non-viable virus. Quantitative PCR provides viral load information useful for monitoring therapy, particularly for feline leukemia virus and feline immunodeficiency virus. Serology detects host antibody responses and is useful for vaccination status assessment and epidemiologic surveillance.

The WOAH terrestrial animal health standards define internationally recognized diagnostic methods and case definitions for reportable viral diseases. These standards guide laboratory confirmation and trade-related testing. Familiarity with notifiable diseases such as foot-and-mouth disease, African swine fever, and highly pathogenic avian influenza is expected for the NAVLE.

Fungal Pathogens and Diagnostic Approaches

Fungal infections divide into superficial, subcutaneous, and systemic categories. Dermatophytes including Microsporum and Trichophyton species infect keratinized tissues and cause circular alopecia with scaling. Diagnosis uses Wood's lamp examination for Microsporum canis, which fluoresces apple-green, and fungal culture on dermatophyte test medium. The medium contains phenol red, which turns red in the presence of dermatophytes but not saprophytic contaminants.

Systemic mycoses include Blastomyces, Histoplasma, Coccidioides, and Cryptococcus. These dimorphic fungi grow as molds in the environment and yeasts in tissue. Blastomyces dermatitidis causes pyogranulomatous pneumonia and skin lesions in dogs. Histoplasma capsulatum infects macrophages and causes pulmonary and disseminated disease. Coccidioides immitis is endemic in arid southwestern regions and causes respiratory disease. Cryptococcus neoformans causes nasal and central nervous system disease in cats.

Diagnosis of systemic mycoses uses cytology, histopathology, culture, and antigen testing. Urine antigen testing for Blastomyces and Histoplasma provides rapid, sensitive diagnosis. Fungal culture requires biosafety precautions because mycelial forms are highly infectious. The MSD Veterinary Manual details the clinical presentation and diagnostic approach for each systemic mycosis.

Diagnostic Specimen Selection and Handling

Specimen quality determines diagnostic yield more than any laboratory test choice. For bacterial culture, collect samples before antimicrobial therapy whenever possible. A single antimicrobial dose can suppress growth for 24 to 48 hours, and prior therapy is the most common cause of false-negative cultures.

Tissue samples outperform swabs for most anaerobic and fastidious organizms. Submit a 1 cm³ tissue cube in a sterile container with a small amount of sterile saline to prevent desiccation. Aerobic swabs are acceptable for superficial infections, but use Amies transport medium with charcoal for organizms susceptible to drying, including Bordetella bronchiseptica and Streptococcus equi subsp. equi. Anaerobic transport requires prereduced media or an anaerobic jar, a routine swab left at room temperature for 30 minutes will not reliably recover Clostridium or Fusobacterium species.

For viral diagnosis, timing matters more than container choice. Acute-phase samples, collected within 3 to 5 days of clinical signs, are optimal for antigen detection and PCR. Convalescent serum collected 2 to 3 weeks later supports serologic confirmation. Paired serology remains the standard for documenting active infection with viruses such as feline coronavirus and equine herpesvirus, where latent or persistent infection confounds single-sample interpretation.

Fungal culture requires separate handling. Dermatophytes grow slowly and may take 14 to 21 days. Collect hair and scale from the active margin of lesions using a sterile brush or forceps, avoiding contaminated surface debris. Systemic fungi such as Blastomyces dermatitidis and Histoplasma capsulatum are best recovered from cytology of impression smears or aspirates before culture is attempted, because culture of these organizms poses a laboratory biohazard and grows slowly.

The ICVA NAVLE candidate information describes the examination's emphasis on clinical reasoning. In practice, this means the diagnostically useful answer is not "which organizm" but "which sample, which test, and which interpretation."

Cytology as a Point-of-Care Diagnostic

Cytology provides same-day identification for many high-yield pathogens and should precede culture in most cases. Romanowsky stains, including Diff-Quik, are adequate for most organizms. Gram stain adds value for bacterial morphology and classification, particularly when distinguishing gram-positive from gram-negative sepsis.

Cytology also detects bacterial overgrowth in the small intestine, a finding that supports a diagnosis of antibiotic-responsive diarrhea when combined with clinical signs and exclusion of other causes. The MSD Veterinary Manual provides species-specific reference ranges for intestinal cytology interpretation, and these ranges differ between dogs and cats.

Culture and Antimicrobial Susceptibility Testing

Culture confirms the etiologic agent and provides susceptibility data, but interpretation requires clinical context. In vitro susceptibility does not guarantee in vivo efficacy. For intracellular organizms such as Brucella canis and Rhodococcus equi, susceptibility testing may show activity that the drug cannot achieve inside cells, and clinical response becomes the more reliable endpoint.

Minimum inhibitory concentration (MIC) values should be interpreted against the Clinical and Laboratory Standards Institute breakpoints for the specific species and infection site. Urinary tract infections in dogs and cats use urine-specific breakpoints that differ from systemic breakpoints. A drug reported as resistant by systemic criteria may still be effective for cystitis because of the high concentrations achieved in urine.

For Staphylococcus pseudintermedius, the primary canine pyoderma pathogen, methicillin resistance is detected by oxacillin or cefoxitin testing. Methicillin-resistant strains are resistant to all beta-lactams regardless of in vitro results, and treatment requires drugs from other classes based on susceptibility. The AVMA practice resources address antimicrobial stewardship expectations for these cases, including the role of topical therapy and the avoidance of fluoroquinolones as first-line agents.

Culture is not indicated for every infection. Toxoplasmosis, neosporosis, and most viral diseases are diagnosed by serology, PCR, or histopathology instead of culture. Mycobacterium species require specialized media, prolonged incubation, and biosafety precautions that most commercial laboratories do not offer routinely.

Molecular Diagnostics and Interpretation Pitfalls

PCR detects nucleic acid, not viable organizms. A positive PCR result does not distinguish active infection from recent vaccination, latent infection, or environmental contamination. This distinction is clinically critical for pathogens such as feline herpesvirus, where latent carriers shed intermittently, and Leptospira species, where PCR on urine can remain positive for weeks after clinical recovery.

Quantitative PCR (qPCR) adds a cycle threshold (Ct) value that correlates inversely with organizm load. Low Ct values, typically below 30, suggest active replication. High Ct values, above 35, may represent low-level shedding or contamination and should be interpreted cautiously. Serial qPCR measurements can monitor treatment response, particularly for Ehrlichia canis and Anaplasma platys, where organizm load falls with effective doxycycline therapy.

PCR panels for respiratory disease in cats and dogs test multiple organizms simultaneously. A positive result for Mycoplasma felis or Bordetella bronchiseptica must be weighed against the high prevalence of these organizms in healthy animals. The WOAH terrestrial animal health standards emphasize that detection of a notifiable pathogen, such as Brucella abortus or foot-and-mouth disease virus, requires confirmation by a reference laboratory before control measures are implemented.

Serology and Its Limitations

Serology detects the host response, not the organizm. A single positive titer cannot distinguish current infection from past exposure or vaccination. Paired acute and convalescent samples, collected 2 to 3 weeks apart, provide the most reliable evidence of active infection when a fourfold or greater rise in titer is documented.

Vaccination confounds serologic interpretation for many pathogens. Bordetella bronchiseptica vaccination in dogs produces serum antibodies that are not protective against infection and do not correlate with clinical immunity. Feline coronavirus serology cannot distinguish enteric strains from feline infectious peritonitis (FIP)-causing mutants, and the diagnosis of FIP relies on histopathology or immunohistochemistry in most cases.

For zoonotic pathogens, serology serves a public health function. Brucella canis screening in breeding kennels uses the rapid slide agglutination test as a screening tool, with confirmatory testing by agar gel immunodiffusion or PCR. Leptospira microscopic agglutination testing (MAT) requires paired samples for definitive diagnosis, and a single high titer in a vaccinated animal is not diagnostic.

Antimicrobial Selection Frameworks

Antimicrobial choice follows a hierarchy: identify the organizm, determine the infection site, assess host factors, then select the narrowest effective drug. Empiric therapy is justified when the patient is unstable or when culture results are pending, but the choice should target the most likely pathogen based on species, signalment, and lesion location.

Host factors alter drug selection. Fluoroquinolones are avoided in juvenile dogs because of cartilage toxicity. Chloramphenicol is avoided in cats because of prolonged elimination. Aminoglycosides require monitoring of renal function, particularly in dehydrated or geriatric patients. The MSD Veterinary Manual provides species-specific contraindications and monitoring recommendations that should be reviewed before prescribing.

Duration of therapy varies by infection site. Uncomplicated cystitis in dogs responds to 7 to 14 days of appropriate therapy. Pyelonephritis requires 3 to 4 weeks. Osteomyelitis and endocarditis require 6 to 8 weeks or longer. Clinical response, not a fixed calendar, should guide the final decision to discontinue therapy, with repeat culture or cytology used to document resolution where relapse is a concern.

Documentation and Reporting

Medical records must document the diagnostic plan, the rationale for antimicrobial selection, and the monitoring parameters used to assess response. Record the specimen type, collection date, and transport method for every culture. Note the laboratory, the accession number, and the date results were received. When susceptibility results conflict with clinical response, document the discrepancy and the reasoning for the chosen course.

For notifiable diseases, reporting obligations take precedence over client confidentiality. The WOAH terrestrial animal health standards list diseases requiring international notification, and national authorities maintain their own lists. Familiarity with local reporting requirements is a professional obligation, not an administrative afterthought.

Recognized Complications and Early Detection

Diagnostic failure in veterinary microbiology usually follows one of several predictable patterns. Sample mishandling produces false negatives before the laboratory receives the specimen. Anaerobic bacteria die on exposure to oxygen, so a swab transported in aerobic medium will yield no growth despite florid infection. Detect this early by confirming that the collection method matches the suspected pathogen class before submission. For anaerobes, aspirate fluid into an anaerobic transport tube or syringe with the air expelled. For viruses, place tissue in viral transport medium or sterile saline, not formalin, unless the goal is histopathology or PCR on fixed tissue.

Antimicrobial susceptibility reporting can mislead when the laboratory tests drugs that are irrelevant to the infection site. An isolate from a skin wound tested against systemic antibiotics may show resistance to a topical agent that would be effective at high local concentration. Conversely, susceptibility in vitro does not guarantee efficacy in vivo when the drug penetrates poorly into the target tissue, such as the central nervous system, prostate, or an abscess cavity. Detect this by reviewing the minimum inhibitory concentration in relation to the expected tissue penetration and by requesting additional testing, such as a beta-lactamase test or inducible clindamycin resistance screening, when the clinical picture does not match the reported susceptibility.

Serologic false positives arise from vaccination, maternal antibody, or cross-reacting organizms. A single elevated titre never confirms active infection. Detect this by pairing acute and convalescent samples collected 2 to 4 weeks apart and by interpreting results in light of vaccination history. The ICVA NAVLE Candidate Information describes the examination's emphasis on clinical reasoning, and that reasoning applies directly here: a titre is a data point, not a diagnosis.

Common Errors and Corrective Actions

Students and early-career clinicians frequently overinterpret Gram stain morphology. A Gram-positive coccus in pairs from a feline abscess suggests staphylococci, but the same morphology from a bovine mastitis sample could be streptococci. The corrective action is to pair morphology with culture results and never to base therapy on a Gram stain alone when the patient is deteriorating.

Another recurring error is submitting the wrong specimen type for the suspected agent. For feline herpesvirus, conjunctival and corneal swabs are appropriate, but a pharyngeal swab often yields false negatives. For rabies, the only valid antemortem samples are saliva and nuchal skin biopsy, and the definitive diagnosis requires brain tissue postmortem. Correct this by consulting a species-specific reference such as the MSD Veterinary Manual before collection when the clinical presentation is atypical.

A third error is treating a contaminant as a pathogen. Coagulase-negative staphylococci from a blood culture may be skin flora, and a single colony of Bacillus species from a urine sample is rarely significant. The corrective action is to require growth in multiple samples or in pure culture from a normally sterile site before committing to therapy.

Troubleshooting Table

Evidence Limitations and Expert Disagreement

The evidence base for veterinary microbiology is uneven across species. Canine and feline infectious disease has robust clinical studies, while food animal and exotic species rely more heavily on extrapolation and case series. Expert opinion differs on the clinical significance of organizms such as Mycoplasma species in the respiratory tract of calves, where colonisation is common and disease is multifactorial. Similarly, the role of antimicrobial susceptibility testing for obligate intracellular pathogens such as Rickettsia and Chlamydia remains contested because in vitro testing does not reliably predict in vivo response. Acknowledge these gaps and state the uncertainty when advising clients or students. The WOAH terrestrial animal health standards provide internationally agreed case definitions for reportable diseases, which can anchor decisions where local evidence is thin.

Referral, Consultation, and Regulatory Reporting

Refer to a veterinary microbiologist or diagnostic laboratory when the clinical picture is severe, the patient is deteriorating despite appropriate therapy, or the isolate is unusual for the species and site. Specialist consultation is warranted for zoonotic pathogens where human exposure has occurred, for immunocompromised patients, and for infections that fail to clear after two appropriate courses of therapy.

Regulatory reporting obligations vary by jurisdiction, but certain agents are notifiable in most regions. Rabies, anthrax, brucellosis, and highly pathogenic avian influenza require immediate reporting to the relevant animal health authority. The AVMA practice resources and WOAH terrestrial animal health standards describe the framework for disease notification and trade implications. When in doubt about whether a condition is reportable, contact the state or provincial veterinarian before releasing the animal or disposing of diagnostic samples. Document the conversation and the advice received in the medical record.

Frequently Asked Questions

How Do I Prioritize Testing When the Owner Has a Limited Diagnostic Budget?

Start with the test most likely to change your treatment or public health recommendation. For a suspected bacterial infection, cytology and Gram stain often outperform culture on cost and speed, and they can guide an initial antimicrobial choice while you await results. Reserve PCR or culture for cases where resistance is likely, the patient is deteriorating, or the infection is zoonotic. If you can afford only one confirmatory test, choose culture with susceptibility testing when treatment failure would be costly. The ICVA NAVLE candidate information emphasizes clinical reasoning under resource constraints, and that same logic applies in practice.

What Should I Do When the Reference Laboratory Rejects My Sample?

Rejection usually reflects improper container, insufficient volume, delayed transport, or missing cold chain. Contact the laboratory before resubmitting to confirm the exact deficiency. For bacterial culture, a sterile swab in transport medium is the minimum acceptable standard. If the sample cannot be replaced, ask whether the laboratory can salvage any testing from what was submitted. Document the rejection in the medical record, including the reason and your corrective action. The MSD Veterinary Manual advises that sample quality determines diagnostic reliability, so a rejected sample should never be interpreted as a negative result.

How Does My Approach Change for a Food Animal Versus a Companion Animal?

The stakes differ in three areas: cost per animal, herd-level impact, and withdrawal periods. In a food animal, a single culture may represent the entire group, so pooled samples or bulk milk testing can be more efficient. Antimicrobial choice must account for labelled withdrawal times and, in some regions, prohibited uses in food-producing species. In companion animals, you can pursue serial sampling and advanced diagnostics more readily. For reportable diseases, the same organizm triggers the same regulatory obligation regardless of species. Consult the WOAH terrestrial animal health standards for disease-specific surveillance expectations that vary by production system.

What Do I Record in the Medical Record for a Suspected Zoonotic Infection?

Record the clinical signs, the diagnostic tests performed, the presumptive or confirmed agent, and the antimicrobial or other treatment prescribed. Note the client education you provided about zoonotic transmission and personal protective measures. If you reported the case to public health or regulatory authorities, document the agency, date, and case number. The AVMA practice resources emphasize that medical records must support continuity of care and legal review. A clear timeline of sample collection, laboratory submission, and result receipt protects you if the case is later questioned.

How Do I Explain a Resistant Infection to a Client Without Undermining Their Trust?

Frame resistance as an expected evolutionary outcome, not a failure of prior treatment. Explain that the bacteria have survived previous drug exposure and that the susceptibility test identifies which drugs will still work. Use the culture report to show the client the specific options. Avoid blaming referring veterinarians or previous prescriptions. Offer a concrete plan: the new drug, the duration, and the follow-up recheck. The AAVMC veterinary education resources stress clear communication as a core clinical competency, and this conversation is a direct application of that skill.

When Is It Acceptable to Treat Empirically Without Culture?

Empirical treatment is acceptable when the infection is mild, the most likely agent has a predictable susceptibility pattern, and the cost of culture exceeds the risk of treatment failure. Examples include uncomplicated canine pyoderma and bovine respiratory disease in the early stages. Culture becomes mandatory when the patient is systemically ill, has failed prior therapy, is immunocompromised, or when the agent is known to have variable resistance. Always collect the sample before starting antimicrobials if there is any chance you will need culture later. The MSD Veterinary Manual notes that empirical therapy should be reassessed within 48 to 72 hours based on clinical response.

Related Clinical & Scientific Guides

• Developing a Study Schedule for NAVLE Diagnostic Reasoning
• Veterinary Physiology Concepts Frequently Tested on the NAVLE
• NAVLE Clinical Rotation Preparation: What to Review Before Each Service

References and Further Reading

• ICVA NAVLE Candidate Information. ICVA.
• AAVMC Veterinary Education Resources. AAVMC.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Veterinary Anatomy High-Yield Topics for the NAVLE
• Veterinary Pharmacology and Toxicology: High-Yield Topics for NAVLE
• NAVLE Microbiology: High-Yield Bacteria and Fungi
• Veterinary Internal Medicine High-Yield Topics for the NAVLE
• Veterinary Parasitology for the NAVLE: High-Yield Parasites

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.